Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zymeworks Inc. | Director | Stock Option (Right to Buy) | 37K | Dec 7, 2023 | Direct | ||
Zymeworks Inc. | Director | Stock Option (Right to Buy) | 9K | May 6, 2021 | Direct | ||
Axsome Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5.8K | Jun 7, 2024 | Direct | ||
ASSEMBLY BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 2.75K | May 29, 2024 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | By Trust | |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | Oct 6, 2023 | Direct |